Health Care/Hospital

YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine

GAITHERSBURG, Md., April 18, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...

2024-04-18 20:00 1

European Wellness Leads Pioneering Down Syndrome Research at Heidelberg University

HEIDELBERG, Germany, April 18, 2024 /PRNewswire/ -- The European Wellness Biomedical Group (EWBG), in collaboration with the European Wellness Academy (EWA), the Baden Research Lab, and Heidelberg University, has announced substantial advances in Down Syndrome research, revealing new neuroanatomi...

2024-04-18 16:17 502

FWD Hong Kong employees fuel changes with every step for Weez Walk 2024: Standing strong for youth mental health

HONG KONG, April 18, 2024 /PRNewswire/ -- Weez Walk 2024 ("Weez Walk"), organised by Weez Project and KELY Support Group (collectively "the organisers") and sponsored by FWD Hong Kong ("FWD"), was recently concluded with remarkable success. The event attracted over 820 participants, united in th...

2024-04-18 15:40 628

Siriraj Hospital Shines Spotlight on TAVI Procedure as Alternative for High-Risk Patients Requiring Aortic Valve Replacement

BANGKOK, April 18, 2024 /PRNewswire/ -- Siriraj Hospital, a leading healthcare institution inThailand, stands at the forefront of aortic valve disease treatment with Transcatheter Aortic Valve Implantation (TAVI). The minimally invasive procedure significantly reduces surgical trauma and post-sur...

2024-04-18 15:01 701

Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build "Australia's next CSL"

MELBOURNE, Australia, April 18, 2024 /PRNewswire/ -- Australia's newest biotech incubatorJumar Bioincubator has officially opened its doors and revealed the first 16 innovative early-stage ventures to take up residency in its much-awaitedMelbourne-based facility at an ...

2024-04-18 11:00 859

One hundred days to the Games: Transport plan ready

PARIS, April 17, 2024 /PRNewswire/ -- The Île-de-France region and Île-de-France Mobilités, as the leading public financiers, after the Government, have invested more than €500 milliontowards the Paris 2024 Olympic and Paralympic Games. This investment encompasses transport, sports infrastructur...

2024-04-17 20:00 1124

Clarivate Launches LatAm Market Tracking Solution in Partnership with Global Health Intelligence Enabling Real-Time Tracking of Medical Device Markets

New solution offers comprehensive tracking and analysis of market share and size inBrazil, Colombia, Argentina, Chile, Peru and Ecuador LONDON, April 17, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released itsLatAm market ...

2024-04-17 16:00 1082

Q1 2024 Revenue and Business Update

MELBOURNE, Australia, April 17, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended31 March 2024 (Q1 2024). Summary: Q1 2024 financial performance  The Company reports unaudi...

2024-04-17 15:05 987

World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders"

MONTREAL, April 17, 2024 /PRNewswire/ -- On April 17, 2024, the global bleeding disorders community will come together to celebrate World Hemophilia Day. The theme of the event this year is "Equitable access for all: recognizing all bleeding disorders". The World Federation of Hemophilia (WFH) vi...

2024-04-17 15:00 815

GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA

— Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant — – World Hepatitis Alliance Supports Global Expansion of Gilead ALL4LIVER Grant by Joining Grant Review Committee – — Vietnamese Organizations Institute of Gastroenterology and Hepatology and ...

2024-04-17 14:03 1027

GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN ASIA

— Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant — – World Hepatitis Alliance Supports Global Expansion of Gilead ALL4LIVER Grant by Joining Grant Review Committee – — Indian Organizations Chennai Liver Foundation and FIND Receive the Grant t...

2024-04-17 11:22 1068

SCG CELL THERAPY AND A*STAR LAUNCH JOINT LABS WITH COLLABORATION NEARING S$30 MILLION TO ADVANCE iPSC TECHNOLOGY TOWARDS SCALABLE GMP MANUFACTURING OF CELLULAR IMMUNOTHERAPIES

* Collaboration aims to develop scalable GMP-grade iPSC manufacturing processes and therapeutic candidates to facilitate research leading to translation of novel cellular immunotherapies. * Launch of the joint labs builds on existing license, research collaboration and Memorandum of Understan...

2024-04-17 10:00 1110

IMG Sends Employees on Fifth Corporate Service Trip with School the World

INDIANAPOLIS, April 16, 2024 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is excited to highlight the success of its 2024 corporate service trip with School the World, a nonprofit organization focused on providing a...

2024-04-16 21:00 986

CSafe Elevates Cell and Gene Therapy Transport with Reusable Cryogenic Solution

MONROE, Ohio, April 16, 2024 /PRNewswire/ -- CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of a new line of cryogenic multi-use dewars for the cell and gene therapy market. The progressive technolog...

2024-04-16 20:47 1166

YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024

GAITHERSBURG, Md., April 16, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...

2024-04-16 20:00 1243

Exploring Pioneering Programs in Medical Integration in the Greater Bay Area: Actively Applying Digital Identity and Global Legal Entity Identifier (LEI)

HONG KONG, April 16, 2024 /PRNewswire/ -- With the rapid development in information technology, digital transformation has become a core driver in promoting the integration of various sectors in the Greater Bay Area (GBA). In the GBA, a pioneering program has been carried out to explore the poten...

2024-04-16 19:05 990

Exyte acquires Kinetics Group to enhance global leadership in high-tech facility solutions

* Kinetics is a globally leading provider of installation services and equipment  * Company serves high-tech industries such as semiconductor, biopharma, and batteries  * 2,500 employees at more than 20 locations worldwide  * Exyte to enter technical facility management business  * Exyte...

2024-04-16 17:00 930

Fundiin Partners with Medpro to Launch BNPL at Over 200 Hospitals and Medical Centers

HO CHI MINH,  Vietnam, April 16, 2024 /PRNewswire/ -- On April 11, 2024, Fundiin and Medpro held a signing ceremony to celebrate their strategic partnership, marking the inaugural launch of a Buy Now Pay Later (BNPL) payment method at over 200 hospitals ...

2024-04-16 14:00 1029

IHH Healthcare Selects Oracle Exadata Platform to Improve Operational Efficiency and Patient Outcomes

One of the world's largest integrated healthcare providers harnesses the power of cloud acrossSingapore and Malaysia to improve operational efficiency SINGAPORE, April 17, 2024 /PRNewswire/ -- Oracle CloudWorld Tour Singapore -- IHH Healthcare (IHH), a world-leading integrated healthcare provide...

2024-04-16 12:00 931

Value innovations address health concerns amid rising costs

AUCKLAND, New Zealand, April 16, 2024 /PRNewswire/ -- Four in 10 consumers worldwide find health and wellbeing nutritional products too expensive, with one-third of users saying that rising costs have made it hard to continue purchasing them. Despite feeling the pinch, health and wellbeing still...

2024-04-16 10:00 1034
12345 ... 553